The pain management nurse follows the recommended protocol for preventing constipation when starting a patien… - NORCET 6 Prelims -2024

NORCET 6 Prelims -2024

Medical Surgical Nursing

Easy

Appeared in: NORCET 6 Prelims -2024

Explanation

Opioids cause constipation primarily by decreasing gastrointestinal motility (peristalsis) through their action on mu-receptors in the gut.
The standard evidence-based protocol is to proactively treat this side effect, as tolerance to the constipating effects of opioids does not typically develop.
A stimulant laxative (like senna or bisacodyl) is essential to directly counteract the reduced motility.
A stool softener (like docusate) is added to combat the increased water absorption and hardening of the stool, making it easier to pass.
This combination approach addresses both the movement and consistency problems created by opioids.

Option A: Adding bulk fiber is often contraindicated in opioid-induced constipation. Without adequate gut motility to move the added bulk, it can congeal and worsen the constipation, potentially leading to a painful obstruction or fecal impaction.
Option B: Enemas are a treatment for existing constipation or fecal impaction, not a preventative (prophylactic) measure. They are used for rescue therapy when a bowel movement has not occurred for several days despite a bowel regimen.
Option C: While increasing fluids and exercise are good general health measures for promoting bowel regularity, they are typically insufficient to overcome the potent pharmacological effect of opioids on the gut.

Visual 1: Table - Comparison of Laxative Types. A table showing the mechanism of action, examples, and specific role in OIC for stimulant, stool softener, bulk-forming, and osmotic laxatives. This clarifies why the combination is superior.
Visual 2: Flowchart - Pathophysiology of OIC. A diagram showing how opioids bind to mu-receptors in the gut, leading to decreased peristalsis and increased water absorption, resulting in hard, difficult-to-pass stool.

Clinical Relevance

Nursing practice connection: Use the key finding related to Prophylactic management of Opioid-Induced Constipation (OIC) to guide bedside assessment, documentation, and the next nursing action.
Proactive management of OIC is a critical nursing responsibility. Unmanaged constipation is a leading cause of patient distress and non-adherence to essential pain medication.
Nurses must educate patients that constipation is an expected side effect of opioids and that a bowel regimen is part of the treatment plan, not just an optional add-on.
Regularly assess bowel function (frequency, consistency, ease of passage) for any patient on opioids and titrate the bowel regimen as needed based on response.

How to Approach the Question

First, identify the core clinical problem: preventing a predictable side effect (constipation) from a specific class of medication (opioids).
Recall the primary mechanism of opioid-induced constipation: it slows down gut movement (peristalsis).
Analyze each option based on its ability to counteract this primary mechanism.
Option A (fiber) adds bulk but doesn't help it move, which can make things worse.
Option B (enemas) is a treatment for a problem that has already occurred, not prevention.
Option C (fluids/exercise) is a general health tip but not powerful enough to fight the drug's effect.

Concept Tested & Keywords

Concept Tested: Prophylactic management of Opioid-Induced Constipation (OIC).
Stem keywords: pain management, preventing constipation, opioids, recommended protocol
Lead-in keywords: recommended protocol
Negative lead-in flag: false

QPJALQBSpYaP3gg8xYXYsJ